Pharma & Healthcare
Global Pneumococcal Vaccine Polyvalent Market Research Report 2025
- Oct 21, 25
- ID: 481629
- Pages: 78
- Figures: 80
- Views: 21
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine Polyvalent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine Polyvalent.
The Pneumococcal Vaccine Polyvalent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Vaccine Polyvalent market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Vaccine Polyvalent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.
By Company
Pfizer
Merck
GlaxoSmithKline
Serum Institute of India
Biological E
Walvax Biotechnology
Sinovac Biotech
Chongqing Zhifei Biological Products
CanSino Biologics
Segment by Type
Prevnar 13
Pneumovax23
Segment by Technology
Pneumococcal Conjugate Vaccine (PCV)
Pneumococcal Polysaccharide Vaccine (PPSV)
Segment by Application
18 Years and Younger
19 to 64 Years Old
65 Years and Older
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccine Polyvalent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccine Polyvalent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Pneumococcal Vaccine Polyvalent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumococcal Vaccine Polyvalent.
The Pneumococcal Vaccine Polyvalent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumococcal Vaccine Polyvalent market comprehensively. Regional market sizes, concerning products by Type, by Application, by Technology and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumococcal Vaccine Polyvalent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Technology and by regions.
By Company
Pfizer
Merck
GlaxoSmithKline
Serum Institute of India
Biological E
Walvax Biotechnology
Sinovac Biotech
Chongqing Zhifei Biological Products
CanSino Biologics
Segment by Type
Prevnar 13
Pneumovax23
Segment by Technology
Pneumococcal Conjugate Vaccine (PCV)
Pneumococcal Polysaccharide Vaccine (PPSV)
Segment by Application
18 Years and Younger
19 to 64 Years Old
65 Years and Older
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumococcal Vaccine Polyvalent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumococcal Vaccine Polyvalent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pneumococcal Vaccine Polyvalent Market Overview
1.1 Product Definition
1.2 Pneumococcal Vaccine Polyvalent by Type
1.2.1 Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prevnar 13
1.2.3 Pneumovax23
1.3 Pneumococcal Vaccine Polyvalent by Technology
1.3.1 Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Technology: 2024 VS 2031
1.3.2 Pneumococcal Conjugate Vaccine (PCV)
1.3.3 Pneumococcal Polysaccharide Vaccine (PPSV)
1.4 Pneumococcal Vaccine Polyvalent by Application
1.4.1 Global Pneumococcal Vaccine Polyvalent Market Value by Application (2024 VS 2031)
1.4.2 18 Years and Younger
1.4.3 19 to 64 Years Old
1.4.4 65 Years and Older
1.5 Global Pneumococcal Vaccine Polyvalent Market Size Estimates and Forecasts
1.5.1 Global Pneumococcal Vaccine Polyvalent Revenue 2020-2031
1.5.2 Global Pneumococcal Vaccine Polyvalent Sales 2020-2031
1.5.3 Global Pneumococcal Vaccine Polyvalent Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Pneumococcal Vaccine Polyvalent Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pneumococcal Vaccine Polyvalent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Date of Enter into This Industry
2.8 Global Pneumococcal Vaccine Polyvalent Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Vaccine Polyvalent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players Market Share by Revenue
2.8.3 Global Pneumococcal Vaccine Polyvalent Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Vaccine Polyvalent Market Scenario by Region
3.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2020-2031
3.2.1 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2020-2025
3.2.2 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2026-2031
3.3 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2020-2031
3.3.1 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2020-2025
3.3.2 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2026-2031
3.4 North America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.4.1 North America Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.4.3 North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.5.3 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Vaccine Polyvalent Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Vaccine Polyvalent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2020-2031)
3.6.3 Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.7.3 Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2031)
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2025)
4.1.2 Global Pneumococcal Vaccine Polyvalent Sales by Type (2026-2031)
4.1.3 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2031)
4.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2031)
4.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2025)
4.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2026-2031)
4.2.3 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2031)
4.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2031)
5.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2025)
5.1.2 Global Pneumococcal Vaccine Polyvalent Sales by Application (2026-2031)
5.1.3 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2031)
5.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2031)
5.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2025)
5.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2026-2031)
5.2.3 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2031)
5.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Pneumococcal Vaccine Polyvalent Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Pneumococcal Vaccine Polyvalent Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Pneumococcal Vaccine Polyvalent Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Company Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute of India Pneumococcal Vaccine Polyvalent Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Biological E
6.5.1 Biological E Company Information
6.5.2 Biological E Description and Business Overview
6.5.3 Biological E Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biological E Pneumococcal Vaccine Polyvalent Product Portfolio
6.5.5 Biological E Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology Pneumococcal Vaccine Polyvalent Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Sinovac Biotech
6.7.1 Sinovac Biotech Company Information
6.7.2 Sinovac Biotech Description and Business Overview
6.7.3 Sinovac Biotech Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sinovac Biotech Pneumococcal Vaccine Polyvalent Product Portfolio
6.7.5 Sinovac Biotech Recent Developments/Updates
6.8 Chongqing Zhifei Biological Products
6.8.1 Chongqing Zhifei Biological Products Company Information
6.8.2 Chongqing Zhifei Biological Products Description and Business Overview
6.8.3 Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Product Portfolio
6.8.5 Chongqing Zhifei Biological Products Recent Developments/Updates
6.9 CanSino Biologics
6.9.1 CanSino Biologics Company Information
6.9.2 CanSino Biologics Description and Business Overview
6.9.3 CanSino Biologics Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CanSino Biologics Pneumococcal Vaccine Polyvalent Product Portfolio
6.9.5 CanSino Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Vaccine Polyvalent Industry Chain Analysis
7.2 Pneumococcal Vaccine Polyvalent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Vaccine Polyvalent Production Mode & Process Analysis
7.4 Pneumococcal Vaccine Polyvalent Sales and Marketing
7.4.1 Pneumococcal Vaccine Polyvalent Sales Channels
7.4.2 Pneumococcal Vaccine Polyvalent Distributors
7.5 Pneumococcal Vaccine Polyvalent Customer Analysis
8 Pneumococcal Vaccine Polyvalent Market Dynamics
8.1 Pneumococcal Vaccine Polyvalent Industry Trends
8.2 Pneumococcal Vaccine Polyvalent Market Drivers
8.3 Pneumococcal Vaccine Polyvalent Market Challenges
8.4 Pneumococcal Vaccine Polyvalent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pneumococcal Vaccine Polyvalent by Type
1.2.1 Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prevnar 13
1.2.3 Pneumovax23
1.3 Pneumococcal Vaccine Polyvalent by Technology
1.3.1 Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Technology: 2024 VS 2031
1.3.2 Pneumococcal Conjugate Vaccine (PCV)
1.3.3 Pneumococcal Polysaccharide Vaccine (PPSV)
1.4 Pneumococcal Vaccine Polyvalent by Application
1.4.1 Global Pneumococcal Vaccine Polyvalent Market Value by Application (2024 VS 2031)
1.4.2 18 Years and Younger
1.4.3 19 to 64 Years Old
1.4.4 65 Years and Older
1.5 Global Pneumococcal Vaccine Polyvalent Market Size Estimates and Forecasts
1.5.1 Global Pneumococcal Vaccine Polyvalent Revenue 2020-2031
1.5.2 Global Pneumococcal Vaccine Polyvalent Sales 2020-2031
1.5.3 Global Pneumococcal Vaccine Polyvalent Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Pneumococcal Vaccine Polyvalent Market Competition by Manufacturers
2.1 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pneumococcal Vaccine Polyvalent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Product Type & Application
2.7 Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Date of Enter into This Industry
2.8 Global Pneumococcal Vaccine Polyvalent Market Competitive Situation and Trends
2.8.1 Global Pneumococcal Vaccine Polyvalent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players Market Share by Revenue
2.8.3 Global Pneumococcal Vaccine Polyvalent Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumococcal Vaccine Polyvalent Market Scenario by Region
3.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2020-2031
3.2.1 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2020-2025
3.2.2 Global Pneumococcal Vaccine Polyvalent Sales by Region: 2026-2031
3.3 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2020-2031
3.3.1 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2020-2025
3.3.2 Global Pneumococcal Vaccine Polyvalent Revenue by Region: 2026-2031
3.4 North America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.4.1 North America Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.4.3 North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.5.1 Europe Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.5.3 Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumococcal Vaccine Polyvalent Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumococcal Vaccine Polyvalent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2020-2031)
3.6.3 Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.7.1 Latin America Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.7.3 Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumococcal Vaccine Polyvalent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2031)
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Type (2020-2025)
4.1.2 Global Pneumococcal Vaccine Polyvalent Sales by Type (2026-2031)
4.1.3 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2031)
4.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2031)
4.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2020-2025)
4.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Type (2026-2031)
4.2.3 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2031)
4.3 Global Pneumococcal Vaccine Polyvalent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2031)
5.1.1 Global Pneumococcal Vaccine Polyvalent Sales by Application (2020-2025)
5.1.2 Global Pneumococcal Vaccine Polyvalent Sales by Application (2026-2031)
5.1.3 Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2031)
5.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2031)
5.2.1 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2020-2025)
5.2.2 Global Pneumococcal Vaccine Polyvalent Revenue by Application (2026-2031)
5.2.3 Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2031)
5.3 Global Pneumococcal Vaccine Polyvalent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Pneumococcal Vaccine Polyvalent Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Pneumococcal Vaccine Polyvalent Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Company Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Pneumococcal Vaccine Polyvalent Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Company Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Serum Institute of India Pneumococcal Vaccine Polyvalent Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Biological E
6.5.1 Biological E Company Information
6.5.2 Biological E Description and Business Overview
6.5.3 Biological E Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biological E Pneumococcal Vaccine Polyvalent Product Portfolio
6.5.5 Biological E Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology Pneumococcal Vaccine Polyvalent Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Sinovac Biotech
6.7.1 Sinovac Biotech Company Information
6.7.2 Sinovac Biotech Description and Business Overview
6.7.3 Sinovac Biotech Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sinovac Biotech Pneumococcal Vaccine Polyvalent Product Portfolio
6.7.5 Sinovac Biotech Recent Developments/Updates
6.8 Chongqing Zhifei Biological Products
6.8.1 Chongqing Zhifei Biological Products Company Information
6.8.2 Chongqing Zhifei Biological Products Description and Business Overview
6.8.3 Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Product Portfolio
6.8.5 Chongqing Zhifei Biological Products Recent Developments/Updates
6.9 CanSino Biologics
6.9.1 CanSino Biologics Company Information
6.9.2 CanSino Biologics Description and Business Overview
6.9.3 CanSino Biologics Pneumococcal Vaccine Polyvalent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CanSino Biologics Pneumococcal Vaccine Polyvalent Product Portfolio
6.9.5 CanSino Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumococcal Vaccine Polyvalent Industry Chain Analysis
7.2 Pneumococcal Vaccine Polyvalent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumococcal Vaccine Polyvalent Production Mode & Process Analysis
7.4 Pneumococcal Vaccine Polyvalent Sales and Marketing
7.4.1 Pneumococcal Vaccine Polyvalent Sales Channels
7.4.2 Pneumococcal Vaccine Polyvalent Distributors
7.5 Pneumococcal Vaccine Polyvalent Customer Analysis
8 Pneumococcal Vaccine Polyvalent Market Dynamics
8.1 Pneumococcal Vaccine Polyvalent Industry Trends
8.2 Pneumococcal Vaccine Polyvalent Market Drivers
8.3 Pneumococcal Vaccine Polyvalent Market Challenges
8.4 Pneumococcal Vaccine Polyvalent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pneumococcal Vaccine Polyvalent Market Value by Technology, (US$ Million) & (2024 VS 2031)
Table 3. Global Pneumococcal Vaccine Polyvalent Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Pneumococcal Vaccine Polyvalent Market Competitive Situation by Manufacturers in 2024
Table 5. Global Pneumococcal Vaccine Polyvalent Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Pneumococcal Vaccine Polyvalent, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Product Type & Application
Table 13. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Pneumococcal Vaccine Polyvalent Sales by Region (2020-2025) & (K Units)
Table 19. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2020-2025)
Table 20. Global Pneumococcal Vaccine Polyvalent Sales by Region (2026-2031) & (K Units)
Table 21. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2026-2031)
Table 22. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2020-2025)
Table 24. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2026-2031)
Table 26. North America Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 28. North America Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 29. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 33. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 34. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2020-2025)
Table 52. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2026-2031)
Table 53. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2025)
Table 54. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2026-2031)
Table 55. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2025)
Table 58. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2026-2031)
Table 59. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2020-2025)
Table 60. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2026-2031)
Table 61. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2020-2025)
Table 62. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2026-2031)
Table 63. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2025)
Table 64. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2026-2031)
Table 65. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2025)
Table 68. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2026-2031)
Table 69. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2020-2025)
Table 70. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2026-2031)
Table 71. Pfizer Company Information
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 74. Pfizer Pneumococcal Vaccine Polyvalent Product
Table 75. Pfizer Recent Developments/Updates
Table 76. Merck Company Information
Table 77. Merck Description and Business Overview
Table 78. Merck Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Merck Pneumococcal Vaccine Polyvalent Product
Table 80. Merck Recent Developments/Updates
Table 81. GlaxoSmithKline Company Information
Table 82. GlaxoSmithKline Description and Business Overview
Table 83. GlaxoSmithKline Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. GlaxoSmithKline Pneumococcal Vaccine Polyvalent Product
Table 85. GlaxoSmithKline Recent Developments/Updates
Table 86. Serum Institute of India Company Information
Table 87. Serum Institute of India Description and Business Overview
Table 88. Serum Institute of India Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Serum Institute of India Pneumococcal Vaccine Polyvalent Product
Table 90. Serum Institute of India Recent Developments/Updates
Table 91. Biological E Company Information
Table 92. Biological E Description and Business Overview
Table 93. Biological E Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Biological E Pneumococcal Vaccine Polyvalent Product
Table 95. Biological E Recent Developments/Updates
Table 96. Walvax Biotechnology Company Information
Table 97. Walvax Biotechnology Description and Business Overview
Table 98. Walvax Biotechnology Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Walvax Biotechnology Pneumococcal Vaccine Polyvalent Product
Table 100. Walvax Biotechnology Recent Developments/Updates
Table 101. Sinovac Biotech Company Information
Table 102. Sinovac Biotech Description and Business Overview
Table 103. Sinovac Biotech Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Sinovac Biotech Pneumococcal Vaccine Polyvalent Product
Table 105. Sinovac Biotech Recent Developments/Updates
Table 106. Chongqing Zhifei Biological Products Company Information
Table 107. Chongqing Zhifei Biological Products Description and Business Overview
Table 108. Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Product
Table 110. Chongqing Zhifei Biological Products Recent Developments/Updates
Table 111. CanSino Biologics Company Information
Table 112. CanSino Biologics Description and Business Overview
Table 113. CanSino Biologics Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. CanSino Biologics Pneumococcal Vaccine Polyvalent Product
Table 115. CanSino Biologics Recent Developments/Updates
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Pneumococcal Vaccine Polyvalent Distributors List
Table 119. Pneumococcal Vaccine Polyvalent Customers List
Table 120. Pneumococcal Vaccine Polyvalent Market Trends
Table 121. Pneumococcal Vaccine Polyvalent Market Drivers
Table 122. Pneumococcal Vaccine Polyvalent Market Challenges
Table 123. Pneumococcal Vaccine Polyvalent Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccine Polyvalent
Figure 2. Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pneumococcal Vaccine Polyvalent Market Share by Type: 2024 & 2031
Figure 4. Prevnar 13 Product Picture
Figure 5. Pneumovax23 Product Picture
Figure 6. Global Pneumococcal Vaccine Polyvalent Market Value by Technology, (US$ Million) & (2020-2031)
Figure 7. Global Pneumococcal Vaccine Polyvalent Market Share by Technology: 2024 VS 2031
Figure 8. Pneumococcal Conjugate Vaccine (PCV) Product Picture
Figure 9. Pneumococcal Polysaccharide Vaccine (PPSV) Product Picture
Figure 10. Global Pneumococcal Vaccine Polyvalent Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Pneumococcal Vaccine Polyvalent Market Share by Application: 2024 & 2031
Figure 12. 18 Years and Younger
Figure 13. 19 to 64 Years Old
Figure 14. 65 Years and Older
Figure 15. Global Pneumococcal Vaccine Polyvalent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pneumococcal Vaccine Polyvalent Market Size (2020-2031) & (US$ Million)
Figure 17. Global Pneumococcal Vaccine Polyvalent Sales (2020-2031) & (K Units)
Figure 18. Global Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) & (2020-2031)
Figure 19. Pneumococcal Vaccine Polyvalent Report Years Considered
Figure 20. Pneumococcal Vaccine Polyvalent Sales Share by Manufacturers in 2024
Figure 21. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players: Market Share by Revenue in Pneumococcal Vaccine Polyvalent in 2024
Figure 23. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 26. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 30. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 31. Germany Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2020-2031)
Figure 38. China Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 49. Latin America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Pneumococcal Vaccine Polyvalent by Type (2020-2031)
Figure 59. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Type (2020-2031)
Figure 60. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Pneumococcal Vaccine Polyvalent by Application (2020-2031)
Figure 62. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Application (2020-2031)
Figure 63. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2020-2031)
Figure 64. Pneumococcal Vaccine Polyvalent Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pneumococcal Vaccine Polyvalent Market Value by Technology, (US$ Million) & (2024 VS 2031)
Table 3. Global Pneumococcal Vaccine Polyvalent Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Pneumococcal Vaccine Polyvalent Market Competitive Situation by Manufacturers in 2024
Table 5. Global Pneumococcal Vaccine Polyvalent Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Pneumococcal Vaccine Polyvalent, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Product Type & Application
Table 13. Global Key Manufacturers of Pneumococcal Vaccine Polyvalent, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pneumococcal Vaccine Polyvalent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine Polyvalent as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Pneumococcal Vaccine Polyvalent Sales by Region (2020-2025) & (K Units)
Table 19. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2020-2025)
Table 20. Global Pneumococcal Vaccine Polyvalent Sales by Region (2026-2031) & (K Units)
Table 21. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2026-2031)
Table 22. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2020-2025)
Table 24. Global Pneumococcal Vaccine Polyvalent Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2026-2031)
Table 26. North America Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 28. North America Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 29. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 33. Europe Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 34. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Pneumococcal Vaccine Polyvalent Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2020-2025)
Table 52. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Type (2026-2031)
Table 53. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2020-2025)
Table 54. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Type (2026-2031)
Table 55. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2020-2025)
Table 58. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Type (2026-2031)
Table 59. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2020-2025)
Table 60. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2026-2031)
Table 61. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2020-2025)
Table 62. Global Pneumococcal Vaccine Polyvalent Sales (K Units) by Application (2026-2031)
Table 63. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2020-2025)
Table 64. Global Pneumococcal Vaccine Polyvalent Sales Market Share by Application (2026-2031)
Table 65. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Pneumococcal Vaccine Polyvalent Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2020-2025)
Table 68. Global Pneumococcal Vaccine Polyvalent Revenue Market Share by Application (2026-2031)
Table 69. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2020-2025)
Table 70. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2026-2031)
Table 71. Pfizer Company Information
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 74. Pfizer Pneumococcal Vaccine Polyvalent Product
Table 75. Pfizer Recent Developments/Updates
Table 76. Merck Company Information
Table 77. Merck Description and Business Overview
Table 78. Merck Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 79. Merck Pneumococcal Vaccine Polyvalent Product
Table 80. Merck Recent Developments/Updates
Table 81. GlaxoSmithKline Company Information
Table 82. GlaxoSmithKline Description and Business Overview
Table 83. GlaxoSmithKline Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. GlaxoSmithKline Pneumococcal Vaccine Polyvalent Product
Table 85. GlaxoSmithKline Recent Developments/Updates
Table 86. Serum Institute of India Company Information
Table 87. Serum Institute of India Description and Business Overview
Table 88. Serum Institute of India Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Serum Institute of India Pneumococcal Vaccine Polyvalent Product
Table 90. Serum Institute of India Recent Developments/Updates
Table 91. Biological E Company Information
Table 92. Biological E Description and Business Overview
Table 93. Biological E Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Biological E Pneumococcal Vaccine Polyvalent Product
Table 95. Biological E Recent Developments/Updates
Table 96. Walvax Biotechnology Company Information
Table 97. Walvax Biotechnology Description and Business Overview
Table 98. Walvax Biotechnology Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Walvax Biotechnology Pneumococcal Vaccine Polyvalent Product
Table 100. Walvax Biotechnology Recent Developments/Updates
Table 101. Sinovac Biotech Company Information
Table 102. Sinovac Biotech Description and Business Overview
Table 103. Sinovac Biotech Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Sinovac Biotech Pneumococcal Vaccine Polyvalent Product
Table 105. Sinovac Biotech Recent Developments/Updates
Table 106. Chongqing Zhifei Biological Products Company Information
Table 107. Chongqing Zhifei Biological Products Description and Business Overview
Table 108. Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Chongqing Zhifei Biological Products Pneumococcal Vaccine Polyvalent Product
Table 110. Chongqing Zhifei Biological Products Recent Developments/Updates
Table 111. CanSino Biologics Company Information
Table 112. CanSino Biologics Description and Business Overview
Table 113. CanSino Biologics Pneumococcal Vaccine Polyvalent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. CanSino Biologics Pneumococcal Vaccine Polyvalent Product
Table 115. CanSino Biologics Recent Developments/Updates
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Pneumococcal Vaccine Polyvalent Distributors List
Table 119. Pneumococcal Vaccine Polyvalent Customers List
Table 120. Pneumococcal Vaccine Polyvalent Market Trends
Table 121. Pneumococcal Vaccine Polyvalent Market Drivers
Table 122. Pneumococcal Vaccine Polyvalent Market Challenges
Table 123. Pneumococcal Vaccine Polyvalent Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pneumococcal Vaccine Polyvalent
Figure 2. Global Pneumococcal Vaccine Polyvalent Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pneumococcal Vaccine Polyvalent Market Share by Type: 2024 & 2031
Figure 4. Prevnar 13 Product Picture
Figure 5. Pneumovax23 Product Picture
Figure 6. Global Pneumococcal Vaccine Polyvalent Market Value by Technology, (US$ Million) & (2020-2031)
Figure 7. Global Pneumococcal Vaccine Polyvalent Market Share by Technology: 2024 VS 2031
Figure 8. Pneumococcal Conjugate Vaccine (PCV) Product Picture
Figure 9. Pneumococcal Polysaccharide Vaccine (PPSV) Product Picture
Figure 10. Global Pneumococcal Vaccine Polyvalent Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Pneumococcal Vaccine Polyvalent Market Share by Application: 2024 & 2031
Figure 12. 18 Years and Younger
Figure 13. 19 to 64 Years Old
Figure 14. 65 Years and Older
Figure 15. Global Pneumococcal Vaccine Polyvalent Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pneumococcal Vaccine Polyvalent Market Size (2020-2031) & (US$ Million)
Figure 17. Global Pneumococcal Vaccine Polyvalent Sales (2020-2031) & (K Units)
Figure 18. Global Pneumococcal Vaccine Polyvalent Average Price (USD/Unit) & (2020-2031)
Figure 19. Pneumococcal Vaccine Polyvalent Report Years Considered
Figure 20. Pneumococcal Vaccine Polyvalent Sales Share by Manufacturers in 2024
Figure 21. Global Pneumococcal Vaccine Polyvalent Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Pneumococcal Vaccine Polyvalent Players: Market Share by Revenue in Pneumococcal Vaccine Polyvalent in 2024
Figure 23. Pneumococcal Vaccine Polyvalent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Pneumococcal Vaccine Polyvalent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 26. North America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 30. Europe Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 31. Germany Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Pneumococcal Vaccine Polyvalent Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Pneumococcal Vaccine Polyvalent Revenue Market Share by Region (2020-2031)
Figure 38. China Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 49. Latin America Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Pneumococcal Vaccine Polyvalent Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Pneumococcal Vaccine Polyvalent Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Pneumococcal Vaccine Polyvalent Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Pneumococcal Vaccine Polyvalent by Type (2020-2031)
Figure 59. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Type (2020-2031)
Figure 60. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Pneumococcal Vaccine Polyvalent by Application (2020-2031)
Figure 62. Global Revenue Market Share of Pneumococcal Vaccine Polyvalent by Application (2020-2031)
Figure 63. Global Pneumococcal Vaccine Polyvalent Price (USD/Unit) by Application (2020-2031)
Figure 64. Pneumococcal Vaccine Polyvalent Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232